Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FAVIPIRAVIR Cause Intentional product use issue? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Intentional product use issue have been filed in association with FAVIPIRAVIR. This represents 1.3% of all adverse event reports for FAVIPIRAVIR.

7
Reports of Intentional product use issue with FAVIPIRAVIR
1.3%
of all FAVIPIRAVIR reports
5
Deaths
1
Hospitalizations

How Dangerous Is Intentional product use issue From FAVIPIRAVIR?

Of the 7 reports, 5 (71.4%) resulted in death, 1 (14.3%) required hospitalization.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FAVIPIRAVIR. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does FAVIPIRAVIR Cause?

Off label use (369) Drug ineffective (56) Drug ineffective for unapproved indication (40) Condition aggravated (29) Covid-19 (26) Disease progression (24) Product use in unapproved indication (18) Covid-19 pneumonia (15) Acute respiratory distress syndrome (14) Acute kidney injury (13)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which FAVIPIRAVIR Alternatives Have Lower Intentional product use issue Risk?

FAVIPIRAVIR vs FEBUXOSTAT FAVIPIRAVIR vs FEDRATINIB FAVIPIRAVIR vs FELBAMATE FAVIPIRAVIR vs FELIS CATUS HAIR FAVIPIRAVIR vs FELODIPINE

Related Pages

FAVIPIRAVIR Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue FAVIPIRAVIR Demographics